Mustafa Shadi Rifaat Bashir

Overview

Hepatobiliary and pancreatic imaging
Liver cancer (hepatocellular carcinoma)
Fatty liver, NAFLD, and NASH
Chronic liver disease and cirrhosis
Pancreatic cancer
Technical development in MRI
Quantitative imaging

Positions

Professor of Radiology in the School of Medicine

2022 School of Medicine

Professor in Medicine in the School of Medicine

2022 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2016 School of Medicine

Education

M.D., University of Iowa 2004

2004 University of Iowa

Publications, Grants & Awards

Grants (58)
Academics Articles (281)
Conference Pages (70)

Showing 1 - 5 of 58

Evaluation of Efficacy, Safety and Tolerability of NGM282-PS-231 - NGM08

2024-2031NGM Biopharmaceuticals, Inc.

Wake Research WAKE03 - BI 1404-0044 A randomised, double-blind, placebo-controlled, multicentre, Phase III trial evaluating long-term efficacy and safety of survodutide weekly injections in adult participants with non-cirrhotic non-alcoholic steatohe

2025-2028M3 Wake Research Inc

BI 1404-0064 A Phase III double-blind, randomized, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non-alcoholic steatohepatit

2025-2028M3 Wake Research Inc

Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Visceral Fat, Lipid Metabolites, and Liver Injury in Young Women

2023-2028University of California - San Francisco

Genomic Imprinting in the Development of NAFLD

2024-2028National Institute of Diabetes and Digestive and Kidney Diseases

Offices & Contact

Dept of Radiology
Durham, NC
27710